These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 25224530)
1. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Mao Z; Lu Z; Hu X Neurology; 2014 Sep; 83(12):1122. PubMed ID: 25224530 [No Abstract] [Full Text] [Related]
8. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. Lechner C; Baumann M; Hennes EM; Schanda K; Marquard K; Karenfort M; Leiz S; Pohl D; Venkateswaran S; Pritsch M; Koch J; Schimmel M; Häusler M; Klein A; Blaschek A; Thiels C; Lücke T; Gruber-Sedlmayr U; Kornek B; Hahn A; Leypoldt F; Sandrieser T; Gallwitz H; Stoffels J; Korenke C; Reindl M; Rostásy K J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):897-905. PubMed ID: 26645082 [TBL] [Abstract][Full Text] [Related]
10. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Sato DK; Callegaro D; Lana-Peixoto MA; Waters PJ; de Haidar Jorge FM; Takahashi T; Nakashima I; Apostolos-Pereira SL; Talim N; Simm RF; Lino AM; Misu T; Leite MI; Aoki M; Fujihara K Neurology; 2014 Feb; 82(6):474-81. PubMed ID: 24415568 [TBL] [Abstract][Full Text] [Related]
11. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives. Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113 [TBL] [Abstract][Full Text] [Related]
12. Quantitative brain lesion distribution may distinguish MOG-ab and AQP4-ab neuromyelitis optica spectrum disorders. Yang L; Li H; Xia W; Quan C; Zhou L; Geng D; Li Y Eur Radiol; 2020 Mar; 30(3):1470-1479. PubMed ID: 31748853 [TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis Optica Spectrum Disorders. Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784 [TBL] [Abstract][Full Text] [Related]
14. Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Höftberger R; Sepulveda M; Armangue T; Blanco Y; Rostásy K; Calvo AC; Olascoaga J; Ramió-Torrentà L; Reindl M; Benito-León J; Casanova B; Arrambide G; Sabater L; Graus F; Dalmau J; Saiz A Mult Scler; 2015 Jun; 21(7):866-874. PubMed ID: 25344373 [TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica spectrum disorders: still evolving and broadening. Fujihara K Curr Opin Neurol; 2019 Jun; 32(3):385-394. PubMed ID: 30893099 [TBL] [Abstract][Full Text] [Related]
16. Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD. Yan Y; Li Y; Fu Y; Yang L; Su L; Shi K; Li M; Liu Q; Borazanci A; Liu Y; He Y; Bennett JL; Vollmer TL; Shi FD Sci China Life Sci; 2016 Dec; 59(12):1270-1281. PubMed ID: 26920678 [TBL] [Abstract][Full Text] [Related]